Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Announces Closing of $3.8 Million Private Placement

Virax Biolabs Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Monkeypox Diagnosis and Immune Profiling Using Proprietary T cell Test Technology

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

Virax Biolabs Presents at H.C. Wainwright’s 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright’s 24th Annual Global Investment Conference in New York, NY